SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Alpha Tau Medical is currently trending as investors react to groundbreaking interim clinical data demonstrating high local disease control rates across multiple tumor types. The community is buzzing with anticipation for upcoming data releases and major oncology conference presentations, driving significant interest in the stock's potential to reach new valuation milestones.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is capturing investor attention following a powerful earnings report that featured a record-setting dividend increase and an $80 billion share buyback. While the community is actively debating the company's valuation and the long-term sustainability of the AI demand cycle, traders are closely monitoring how market volatility and options positioning will influence near-term price action.

NIO, Inc. operates as a holding company, which engages in the design, development, manufacture, and sale of smart electric vehicles. It offers its products under the brands NIO, ONVO, and FIREFLY. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Shanghai, China.

NIO Inc - ADR

NIO Inc

NIO is trending as the community debates a potential earnings catalyst and expresses deep frustration over persistent price suppression and structural volatility leading up to the report. Investors are actively discussing the stock's long-term value against significant margin pressure and sector competition, while many remain divided between holding for a fundamental turnaround and labeling the stock a perpetual trap.

Applied Digital Corporation

Applied Digital is trending as investors react to a significant lease agreement with a hyperscaler that pushes the companys total contracted AI capacity past the gigawatt threshold. Community sentiment remains largely bullish, with active discussions focusing on the companys robust long-term pipeline, institutional backing, and the ongoing buildout of AI factory infrastructure despite recent sector-wide volatility.

Intuit, Inc. engages in the provision of business and financial management solutions. It operates through the following segments: Small Business and Self-Employed, Consumer, Credit Karma, and ProTax. The Small Business and Self-Employed segment offers QuickBooks financial and business management online services and desktop software, payroll solutions, payment processing solutions, and financing for small businesses. The Consumer segment includes do-it-yourself and assisted TurboTax income tax preparation products and services. The Credit Karma segment serves consumers with a personal finance platform that provides personalized recommendations of credit cards, home, auto and personal loans, and insurance products, and online savings and checking accounts. The ProTax segment refers to the professional accountants in the U.S. and Canada, who are essential to both small business success and tax preparation and filing. The company was founded by Scott D. Cook and Thomas A. Proulx in March 1983 and is headquartered in Mountain View, CA.

Intuit Inc

Intuit shares are experiencing significant volatility following a double earnings beat and upward guidance, which was overshadowed by news of a 17% workforce reduction aimed at AI-focused restructuring. Community sentiment is deeply divided between those viewing the price drop as a "buy the dip" opportunity in a high-quality SaaS leader and skeptics who fear long-term disruption from generative AI tools impacting the tax software and small business accounting markets.

e.l.f. Beauty, Inc. is a holding company, which engages in the provision of inclusive, accessible, clean, vegan and cruelty free cosmetics and skin care products. The company focuses on the e-commerce, national retailers and international business channels. Its brands include elf, elf skin, naturium, well people, and keys soulcare. The company was founded in 2004 and is headquartered in Oakland, CA.

e.l.f. Beauty Inc

e.l.f. Beauty is trending due to an earnings report that featured a strong topline beat alongside a cautious outlook, prompting significant debate over the company's growth trajectory and its ability to navigate inflationary pressures. The community is actively divided between bulls who view the stock as a deeply oversold value opportunity with massive long-term runway and bears who point to financial headwinds and soft forward guidance as evidence of potential further downside.

T1 Energy, Inc. engages in developing battery solutions. It focuses on energy storage systems and commercial mobility. The company was founded by Tom Einar Jensen, Peter Matrai, and Tore Ivar Slettemoen on August 31, 2023 and is headquartered in Austin, TX.

T1 Energy Inc.

T1 Energy is experiencing heightened momentum as community members discuss a massive short squeeze following the company's rejection of a negative short seller report. Investors are also closely monitoring the stock due to significant institutional accumulation and the firm's strategic positioning within the AI and domestic power infrastructure sector.

Hyperliquid is a layer one (L1) blockchain best known for perpetual futures and spot trading. Beyond its flagship DEX trading platform, the ecosystem supports borrowing, lending, real world assets (RWAs), and a full-fledged Ethereum Virtual Machine (EVM), making it a leading force in decentralized finance (defi).   Just as electronic trading dramatically improved markets in the 2000s, Hyperliquid offers an opportunity for a massive technical upgrade of the existing financial system through a transparent, efficient, and resilient blockchain. HYPE is the native token of the Hyperliquid blockchain, with a maximum supply of 1 billion.

Hype

$HYPE.X is generating significant buzz as a high-performance decentralized exchange that is attracting institutional interest and driving massive trading volume. Community discussions are centered on its competitive edge over traditional crypto infrastructure, with many debating the impact of upcoming token unlocks and the potential for a long-term shift toward on-chain perp trading.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group is trending following news of a significant fuel cell partnership with Bloom Energy to power its AI data centers, alongside reports of substantial GPU price hikes. The community remains divided, with bulls pointing to the company's aggressive infrastructure scaling and cloud demand, while bears voice concerns over heavy debt and potential overvaluation.

JD.com, Inc. is a technology-driven E-commerce company, which engages in the sale of electronics products and general merchandise products, including audio, video products, and books. It operates in the following segments: JD Retail, JD Logistics, and New Businesses. The JD Retail segment offers online retail, online marketplace, and marketing services. The JD Logistics segment includes internal and external logistics businesses. The New Businesses segment is composed of JD Property, Jingxi, overseas businesses and technology initiatives. The company was founded on June 18, 1998, by Qiang Dong Liu and is headquartered in Beijing, China.

JD.com Inc - ADR

JD.com is attracting renewed investor interest as shares rally on the back of positive sentiment surrounding potential regulatory easing in the Chinese e-commerce sector. The community is actively discussing a possible re-rating of the stock, driven by strong fundamentals and speculation about upcoming high-level diplomatic meetings.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$ALT If you don&#39;t think the FDA isn&#39;t taking a hard look at $ALT, you&#39;re likely not following.  Things of &quot;possible interest&quot; for the FDA regarding $ALT: 
 
1) Placebo in MASH trial outperformed $ETNB and $MDGL drug arms.  (Note - this board will hype the placebo as being an anomaly, but $ALT&#39;s robust biopsy reads eliminated ANY concern about this.  What&#39;s presented are TRUE results.  Oh, and they failed their TRUE fibrosis Primary endpoint.  
 
2) FDA spent a lot of time money and resources to help $ALT design their P3 Program for Obesity; $ALT has since decided not to pursue it. 
 
3) $ALT has admitted to misdosing in their MASH P2b trial.  They did not disclose this at 24W topline readout.  Details and FDA involvement is unknown at this point, but this would be of a great interest to the FDA. 
 
4) $ALT performed an invasive test on a subject unnecessarily.  Again, the FDA will be interested in this.   
 
5) Previous misleading claims about Pemvi&#39;s benefits for LMP should be of interest to FDA.   
 
Cheers

StockTwits Web

Altimmune Inc

89bio Inc

Madrigal Pharmaceuticals Inc

 If you don't think the FDA isn't taking a hard look at 

, you're likely not following.  Things of "possible interest" for the FDA regarding 

: 
 
1) Placebo in MASH trial outperformed 

 drug arms.  (Note - this board will hype the placebo as being an anomaly, but 

's robust biopsy reads eliminated ANY concern about this.  What's presented are TRUE results.  Oh, and they failed their TRUE fibrosis Primary endpoint.  
 
2) FDA spent a lot of time money and resources to help 

 has since decided not to pursue it. 
 
3) 

 has admitted to misdosing in their MASH P2b trial.  They did not disclose this at 24W topline readout.  Details and FDA involvement is unknown at this point, but this would be of a great interest to the FDA. 
 
4) 

 performed an invasive test on a subject unnecessarily.  Again, the FDA will be interested in this.   
 
5) Previous misleading claims about Pemvi's benefits for LMP should be of interest to FDA.   
 
Cheers

The Legendary Mayor

@BioRich when you say &quot;Placebo in MASH trial outperformed $ETNB and $MDGL drug arms. &quot;  what are you referring to?  Is that an erroneous claim made by $ALT or some trial data that I&#39;m not familiar with?

 when you say "Placebo in MASH trial outperformed 

 drug arms. "  what are you referring to?  Is that an erroneous claim made by 

 or some trial data that I'm not familiar with?

Winston wolf

@winston_www Great question. It was a point towards $ALT pumpers that their 27.9% responder rate for fibrosis improvement without worsening of MASH&quot; is a higher number than 89Bio and Madrigal had for their drug arm.  

This was meant to higglight the concerns in $ALT&#39;s trials, not take away from 89 of MD. 

Thanks for asking.  Hope this helps!

StockTwits For Android 

 pumpers that their 27.9% responder rate for fibrosis improvement without worsening of MASH" is a higher number than 89Bio and Madrigal had for their drug arm.  

This was meant to higglight the concerns in 

's trials, not take away from 89 of MD. 

Thanks for asking.  Hope this helps!